214 related articles for article (PubMed ID: 26951092)
1. Snail heterogeneity in clear cell renal cell carcinoma.
Zaldumbide L; Erramuzpe A; Guarch R; Pulido R; Cortés JM; López JI
BMC Cancer; 2016 Mar; 16():194. PubMed ID: 26951092
[TBL] [Abstract][Full Text] [Related]
2. High levels of intratumor heterogeneity characterize the expression of epithelial-mesenchymal transition markers in high-grade clear cell renal cell carcinoma.
Guarch R; Lawrie CH; Larrinaga G; Angulo JC; Pulido R; López JI
Ann Diagn Pathol; 2018 Jun; 34():27-30. PubMed ID: 29661723
[TBL] [Abstract][Full Text] [Related]
3. Large (>3.8 cm) clear cell renal cell carcinomas are morphologically and immunohistochemically heterogeneous.
Zaldumbide L; Erramuzpe A; Guarch R; Cortés JM; López JI
Virchows Arch; 2015 Jan; 466(1):61-6. PubMed ID: 25369891
[TBL] [Abstract][Full Text] [Related]
4. Intratumor heterogeneity in clear cell renal cell carcinoma: a review for the practicing pathologist.
López JI
APMIS; 2016 Mar; 124(3):153-9. PubMed ID: 26865355
[TBL] [Abstract][Full Text] [Related]
5. Low-grade metastases in high-grade clear cell renal cell carcinomas: A clinicopathologic study of 4 cases with an insight into the role of mesenchymal-to-epithelial transition process.
López JI; Mosteiro L; Guarch R; Larrinaga G; Pulido R; Angulo JC
Ann Diagn Pathol; 2016 Feb; 20():13-8. PubMed ID: 26616721
[TBL] [Abstract][Full Text] [Related]
6. Renal Neoplasms With Overlapping Features of Clear Cell Renal Cell Carcinoma and Clear Cell Papillary Renal Cell Carcinoma: A Clinicopathologic Study of 37 Cases From a Single Institution.
Dhakal HP; McKenney JK; Khor LY; Reynolds JP; Magi-Galluzzi C; Przybycin CG
Am J Surg Pathol; 2016 Feb; 40(2):141-54. PubMed ID: 26752401
[TBL] [Abstract][Full Text] [Related]
7. Sarcomatoid renal cell carcinoma is an example of epithelial--mesenchymal transition.
Conant JL; Peng Z; Evans MF; Naud S; Cooper K
J Clin Pathol; 2011 Dec; 64(12):1088-92. PubMed ID: 22003062
[TBL] [Abstract][Full Text] [Related]
8. Renal cell carcinoma in young adults: a study of 130 cases and a review of previous series.
López JI; Moreno V; García H; Antón I; Robles A; Oñate JM; Baños A; Escandón J; Ugalde A
Urol Int; 2010; 84(3):292-300. PubMed ID: 20389158
[TBL] [Abstract][Full Text] [Related]
9. Pathological Bases and Clinical Impact of Intratumor Heterogeneity in Clear Cell Renal Cell Carcinoma.
López JI; Angulo JC
Curr Urol Rep; 2018 Jan; 19(1):3. PubMed ID: 29374850
[TBL] [Abstract][Full Text] [Related]
10. The utility of tetraspanin CD9 as a biomarker for metastatic clear cell renal cell carcinoma.
Garner JM; Herr MJ; Hodges KB; Jennings LK
Biochem Biophys Res Commun; 2016 Feb; 471(1):21-5. PubMed ID: 26855131
[TBL] [Abstract][Full Text] [Related]
11. Clear cell renal cell carcinoma with a syncytial-type multinucleated giant tumor cell component: implications for differential diagnosis.
Williamson SR; Kum JB; Goheen MP; Cheng L; Grignon DJ; Idrees MT
Hum Pathol; 2014 Apr; 45(4):735-44. PubMed ID: 24499686
[TBL] [Abstract][Full Text] [Related]
12. New cut-off point between T1 and T2 renal cell carcinoma - necessary for a better discriminatory power of the TNM classification.
Wunderlich H; Dreihaupt M; Schlichter A; Kosmehl H; Reichelt O; Schubert J
Urol Int; 2004; 72(2):123-8. PubMed ID: 14963352
[TBL] [Abstract][Full Text] [Related]
13. Dysregulation of β-catenin is an independent predictor of oncologic outcomes in patients with clear cell renal cell carcinoma.
Krabbe LM; Westerman ME; Bagrodia A; Gayed BA; Darwish OM; Haddad AQ; Khalil D; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
J Urol; 2014 Jun; 191(6):1671-7. PubMed ID: 24291548
[TBL] [Abstract][Full Text] [Related]
14. Expression of EphA2 protein is positively associated with age, tumor size and Fuhrman nuclear grade in clear cell renal cell carcinomas.
Wang L; Hu H; Tian F; Zhou W; Zhou S; Wang J
Int J Clin Exp Pathol; 2015; 8(10):13374-80. PubMed ID: 26722543
[TBL] [Abstract][Full Text] [Related]
15. Significance of nuclear grade and tumor size in Korean patients with chromophobe renal cell carcinoma: a comparison with conventional renal cell carcinoma.
Ku JH; Moon KC; Kwak C; Kim HH
Urol Oncol; 2011; 29(5):487-91. PubMed ID: 19767221
[TBL] [Abstract][Full Text] [Related]
16. Clear cell papillary renal cell carcinoma is an indolent and low-grade neoplasm with overexpression of cyclin-D1.
Leroy X; Camparo P; Gnemmi V; Aubert S; Flamand V; Roupret M; Fantoni JC; Comperat E
Histopathology; 2014 Jun; 64(7):1032-6. PubMed ID: 24382138
[TBL] [Abstract][Full Text] [Related]
17. Loss of PD-L1 (SP-142) expression characterizes renal vein tumor thrombus microenvironment in clear cell renal cell carcinoma.
López JI; Pulido R; Lawrie CH; Angulo JC
Ann Diagn Pathol; 2018 Jun; 34():89-93. PubMed ID: 29661736
[TBL] [Abstract][Full Text] [Related]
18. Expression of kidney-specific cadherin distinguishes chromophobe renal cell carcinoma from renal oncocytoma.
Mazal PR; Exner M; Haitel A; Krieger S; Thomson RB; Aronson PS; Susani M
Hum Pathol; 2005 Jan; 36(1):22-8. PubMed ID: 15712178
[TBL] [Abstract][Full Text] [Related]
19. Small renal tumors: correlation of clinical and pathological features with tumor size.
Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
[TBL] [Abstract][Full Text] [Related]
20. Expression of epithelial-mesenchymal transition markers in renal cell carcinoma: impact on prognostic outcomes in patients undergoing radical nephrectomy.
Harada K; Miyake H; Kusuda Y; Fujisawa M
BJU Int; 2012 Dec; 110(11 Pt C):E1131-7. PubMed ID: 22712620
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
